New Developments in the Management of Opioid Dependence: Focus on Sublingual Buprenorphine–naloxone

Substance Abuse and Rehabilitation
doi 10.2147/sar.s45585
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited